E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/9/2007 in the Prospect News PIPE Daily.

New Issue: ImmunoCellular raises $2.26 million in stock offering

By Sheri Kasprzak

New York, May 9 - ImmunoCellular Therapeutics, Ltd. completed a $2,262,252 private placement of its stock.

The company sold 1,508,168 shares at $1.50 each.

The investors also received warrants for 1,508,168 shares, exercisable at $2.50 each for two years.

ImmunoCellular, based in Los Angeles, develops cellular treatments for brain cancer and neurodegenerative disorders.

Issuer:ImmunoCellular Therapeutics, Ltd.
Issue:Stock
Amount:$2,262,252
Shares:1,508,168
Price:$1.50
Warrants:One warrant per share
Warrant expiration:Two years
Warrant strike price:$2.50
Settlement date:May 7
Stock symbol:OTCBB: IMUC
Stock price:$2.15 at close May 7

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.